An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing

A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk

(2011) C. L. Alden et al.   VETERINARY PATHOLOGY

Critical Review of Preclinical Approaches to Evaluate the Potential of Immunosuppressive Drugs to Influence Human Neoplasia

(2010) Peter J. Bugelski et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays

(2010) Samuel M. Cohen   TOXICOLOGIC PATHOLOGY

An Evaluation of Chronic 6- and 12-Month Rat Toxicology Studies as Predictors of 2-Year Tumor Outcome

(2010) M. V. Reddy et al.   VETERINARY PATHOLOGY

Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach

(2009) Lya G. Hernández et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Cancer Risk Assessment Approaches at the FDA/CDER: Is the Era of the 2-Year Bioassay Drawing to a Close?

(2009) David Jacobson-Kram   TOXICOLOGIC PATHOLOGY

An Industry Perspective on the Utility of Short-Term Carcinogenicity Testing in Transgenic Mice in Pharmaceutical Development

(2009) Richard D. Storer et al.   TOXICOLOGIC PATHOLOGY

Radiation-induced bystander effects in vivo are epigenetically regulated in a tissue-specific manner

(2008) Yaroslav Ilnytskyy et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS